On June 5th, important partners from the Eurasian region visited Shandong Junxiu Biotechnology Co., Ltd. The two sides reached multiple substantive consensuses in cooperation in the Eurasian market, marking a key breakthrough in Junxiu Biotechnology’s overseas layout.
Our partners conducted an in-depth investigation of the company’s research and development capabilities, large-scale production capacity, and international compliance quality system. This negotiation is pragmatic and clear. Both parties will explore core cooperation issues such as the landing and sales of products in the Eurasian region and the joint construction of local channels, and determine to rely on local resources to build a localized sales and after-sales system.
In the future, Junxiu Biotechnology will accelerate the implementation of overseas market policies, continue to deepen its overseas strategic layout, expand its international market share and brand influence, and serve global patients with high-quality products.